Vabicaserin hydrochloride

CAS: 887258-94-8

Ref. 3D-MKB25894

Produktinformation

• Name: Vabicaserin hydrochloride
• Synonyme: Cyclopenta[4,5]pyrido[3,2,1-jk][1,4]benzodiazepine, 4,5,6,7,9,9a,10,11,12,12a-decahydro-, monohydrochloride, (9aR,12aS)-, Cyclopenta[4,5]pyrido[3,2,1-jk][1,4]benzodiazepine, 4,5,6,7,9,9a,10,11,12,12a-decahydro-, hydrochloride (1:1), (9aR,12aS)-, SCA 136

Beschreibung

Vabicaserin hydrochloride is a potent and selective 5-HT2C receptor antagonist. It is used as a treatment for obesity, type 2 diabetes, or neuropathic pain due to its effects on the serotonergic system. This drug inhibits the production of glucose by inhibiting the sodium-dependent glucose transporter in rat liver microsomes. Vabicaserin hydrochloride has been shown to inhibit the activity of 5-HT1A receptors in vitro assays and has an inhibitory effect on infectious diseases and autoimmune diseases. This drug also increases dopamine release in striatal tissues via inhibition of dopamine reuptake.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 264.79 g/mol
• Formel: C₁₅H₂₁ClN₂
• Reinheit: Min. 95%